Proof-of-concept Lymfif (QI_LF)

McGill University

Status: Completed

Conditions: Quality of Life

Treatments: Behavioral: Lymfit intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT05546489

QI_LF

Details and patient eligibility

About

This proof-of-concept study was to explore the implementation feasibility to deliver the Lymfit intervention to participants remotely during the pandemic.

Enrollment: 20 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 1. previously diagnosed with lymphoma
• 2. have completed chemotherapy
• 3. had access to a smart phone or an electronic device (e.g., tablet) that allowed them to attend virtual meetings and install the Fitbit application

Exclusion criteria

-1. have any contra-indications to performing physical activities as determined by the hematologist

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Lymfit intervention

Experimental group

Description:

Participants will receive a Fitbit wearable tracker, expert guidance, and a personalized exercise prescription to optimize physical activities among lymphoma survivors. The intervention is 12 weeks long, participants are meeting with a kinesiologist every 2 weeks.

Treatment:

Behavioral: Lymfit intervention